AVITA Medical, Inc.
RCEL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $139,484 | $213,704 | $334,672 | $278,548 |
| - Cash | $12,216 | $14,870 | $14,050 | $18,639 |
| + Debt | $44,588 | $44,073 | $45,985 | $45,626 |
| Enterprise Value | $171,856 | $242,907 | $366,607 | $305,535 |
| Revenue | $18,418 | $18,514 | $18,406 | $19,546 |
| % Growth | -0.5% | 0.6% | -5.8% | – |
| Gross Profit | $14,949 | $15,681 | $16,126 | $16,356 |
| % Margin | 81.2% | 84.7% | 87.6% | 83.7% |
| EBITDA | -$8,112 | -$12,097 | -$9,863 | -$14,564 |
| % Margin | -44% | -65.3% | -53.6% | -74.5% |
| Net Income | -$9,920 | -$13,859 | -$11,589 | -$16,205 |
| % Margin | -53.9% | -74.9% | -63% | -82.9% |
| EPS Diluted | -0.38 | -0.53 | -0.44 | -0.62 |
| % Growth | 28.3% | -20.5% | 29% | – |
| Operating Cash Flow | -$10,229 | -$10,309 | -$8,081 | -$7,214 |
| Capital Expenditures | -$524 | -$234 | -$1,634 | -$3,816 |
| Free Cash Flow | -$10,753 | -$10,543 | -$9,715 | -$11,030 |